Illumina files new patent infringement suit against Ariosa Diagnostics

28-04-2014 Business Wire HealthComments (0)


Illumina (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. Illumina is seeking all available remedies, including injunctive relief. The new suit, filed in the U.S. District Court for the Northern District of California, is based on Ariosa’s infringement of U.S. Patent No. 7,955,794, entitled “Multiplex Nucleic Acid Reactions.” The suit targets Ariosa’s Harmony™ Prenatal Test, including its use of

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top